Accumulating evidence indicates that miRNAs play important roles in AD pathogenesis through the regulation of genes involved in amyloid processing, tau phosphorylation, and neurodegeneration (Wang et al., 2019; Kou et al., 2020; Guévremont et al., 2022). This evidence concerns the gene MAPT and Alzheimer disease.